Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
25.3M
-
Shares change
-
-13.9M
-
Total reported value, excl. options
-
$4.99M
-
Value change
-
-$3.52M
-
Number of buys
-
7
-
Number of sells
-
-24
-
Price
-
$0.20
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q3 2018
41 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q3 2018.
REGULUS THERAPEUTICS INC - COM (RGLS) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.3M shares
.
Largest 10 shareholders include BVF INC/IL (13.7M shares), FMR LLC (3.96M shares), Vanguard Group Inc (2.61M shares), ASCEND CAPITAL, LLC (1.05M shares), RENAISSANCE TECHNOLOGIES LLC (596K shares), BlackRock Inc. (586K shares), RHENMAN & PARTNERS ASSET MANAGEMENT AB (493K shares), GEODE CAPITAL MANAGEMENT, LLC (484K shares), South Dakota Investment Council (368K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (293K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.